Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.001 Å; R factor = 0.039; wR factor = 0.123; data-to-parameter ratio = 22.5.
In the title compound, C 6 H 10 N 2 O, the 2,3-dihydro-1Hpyrazole ring is approximately planar, with a maximum deviation of 0.013 (1) Å . Pairs of intermolecular N-HÁ Á ÁO hydrogen bonds link neighboring molecules into dimers, generating R 2 2 (8) ring motifs. These dimers are further linked into two-dimensional arrays parallel to the bc plane by intermolecular N-HÁ Á ÁO hydrogen bonds. The crystal structure is further stabilized by C-HÁ Á Á interactions.
Related literature
For the background to and the biological activity of 3-ethyl-4methyl-1H-pyrazol-5-ol, see: Brogden (1986) ; Coersmeier et al. (1986) ; Gursoy et al. (2000) ; Ragavan et al. (2009 Ragavan et al. ( , 2010 ; Watanabe et al. (1984) ; Kawai et al. (1997) ; Wu et al. (2002) . For related structures, see: Shahani et al. (2009 Shahani et al. ( , 2010 . For hydrogen-bond motifs, see: Bernstein et al. (1995) . For reference bond-length data, see: Allen et al. (1987) . For the stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986 Table 1 Hydrogen-bond geometry (Å , ).
Cg1 is the centroid of the 1H-pyrazole ring (C1-C3/N1/N2). Symmetry codes: (i) Àx þ 1; Ày þ 1; Àz; (ii) x; Ày þ 3 2 ; z À 1 2 ; (iii) Àx; y þ 1 2 ; Àz À 1 2 .
D-HÁ
Data collection: APEX2 (Bruker, 2009 ); cell refinement: SAINT (Bruker, 2009 ); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 
Vijayakumar and S. Sarveswari
Comment Pyrazolone derivatives have a broad spectrum of biological activities as analgesic, antipyretic and anti-inflammatory therapeutical drugs (Brogden, 1986; Gursoy et al., 2000) . A class of new pyrazolone compounds have been synthesized and reported to exhibit antibacterial and antifungal activities (Ragavan et al., 2010; Ragavan et al., 2009) . A new pyrazolone derivative, edaravone (5-ethyl-4-methyl-1H-pyrazol-3(2H)-one), is being used as a drug in clinical practice for brain ischemia (Watanabe et al., 1984; Kawai et al., 1997) and it has also been found to be effective against myocardial ischemia (Wu et al., 2002) .
In the crystal structure ( Fig. 1) , the 2,3-dihydro-1H-pyrazole ring (C1-C3/N1/N2) is approximately planar with a maximum deviation of 0.013 (1) Å for atoms N1 and N2 (but they are on opposite sides of the plane). The bond lengths (Allen et al., 1987) and angles are within normal ranges and comparable to those in closely related structures reported recently (Shahani et al., 2009; 2010) .
In the crystal packing (Fig. 2) , pairs of intermolecular N1-H1N1···O1 hydrogen bonds (Table 1) link neighboring molecules into dimers, generating R 2 2 (8) ring motifs (Bernstein et al., 1995) . These dimers are further linked into 2D arrays parallel to the bc plane by intermolecular N2-H1N2···O1 hydrogen bonds (Table 1) . The crystal structure is further stabilized by a C-H···π interaction (Table 1) , involving the C1-C3/N1/N2 ring (centroid Cg1) .
Experimental
The compound 5-ethyl-4-methyl-1H-pyrazol-3(2H)-one has been synthesized using the method reported in the literature (Ragavan et al., 2009 (Ragavan et al., , 2010 and purified by column chromatography (MeOH: EtOAc, 1:99). It was recrystallised as a colourless solid, using ethanol. Mp: 496.4-507.1 K; MS calculated for C 6 H 10 N 2 O: 126.15. Found: 128.0 (M+).
Refinement
All hydrogen atoms were located in a difference map and were refined freely [N-H = 0.902 (14) 
5-Ethyl-4-methyl-1H-pyrazol-3(2H)-one

Special details
Experimental. The crystal was placed in the cold stream of an Oxford Cyrosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986) operating at 100.0 (1) K.
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating Rfactors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 ) (11) C1-N1-N2 109.19 (6) C5-C4-H4A 109.8 (8) C1-N1-H1N1 124.9 (9) C3-C4-H4B 110.2 (7) N2-N1-H1N1 125.8 (9) C5-C4-H4B 107.8 (7) C3-N2-N1 108.49 (6) H4A-C4-H4B 107.7 (11) C3-N2-H1N2
128.1 (8) C4-C5-H5A 114.0 (8) N1-N2-H1N2 123.1 (8) C4-C5-H5B 111.0 (9) O1-C1-N1 122.64 (7) H5A-C5-H5B 106.9 (12) O1-C1-C2 130.32 (6) C4-C5-H5C 111.5 (9) N1-C1-C2 107.04 (6) H5A-C5-H5C 106.6 (12) C3-C2-C1 105.99 (6) H5B-C5-H5C 106.3 (12) C3-C2-C6 128.98 (7) C2-C6-H6A 113.4 (8) C1-C2-C6 125.03 (6) C2-C6-H6B 112.5 (9) N2-C3-C2 109.23 (6) H6A-C6-H6B 103.1 (11) N2-C3-C4 120.16 (7) C2-C6-H6C 110.4 (10) C2-C3-C4 130.59 (7) H6A-C6-H6C 110.9 (12) C3-C4-C5 113.02 (7) H6B-C6-H6C 106.1 (13) C3-C4-H4A 108.2 (8) Fig. 1 supplementary materials sup-7 Fig. 2 
